Markets:

Overview

News

Currencies

International

Treasuries

Neumora Therapeutics, Inc. - Common Stock (NQ:NMRA)

3.095 +0.075 (+2.48%)

Streaming Delayed Price Updated: 9:47 AM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neumora Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

Analyst Expectations for Neumora Therapeutics's Future ↗

November 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 22, 2023

Via Benzinga

Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday ↗

December 22, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition...

Via Benzinga

Topics Stocks

7 Stocks with Strong Insider Buying: December 2023 ↗

December 17, 2023

Here are just a few of the top stocks with strong insider buying that all investors may want to watch heading into 2024.

Via InvestorPlace

Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer

December 12, 2023

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 04, 2023

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...

Via Benzinga

Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 30, 2023

Shares of Salesforce, Inc.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 30, 2023

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

Via InvestorPlace

Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study

November 27, 2023

NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor, a clinically validated target for the treatment of schizophrenia

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

November 01, 2023

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics to Participate in Upcoming Conferences in November

October 30, 2023

From Neumora Therapeutics, Inc.

Via GlobeNewswire

PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday ↗

October 10, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 ↗

October 10, 2023

Via Benzinga

Why Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder Drug ↗

October 10, 2023

Shares of Neumora Therapeutics Inc (NASDAQ: NMRA) were trading lower on Tuesday, a month after the company announced its IPO on the NASDAQ exchange.

Via Benzinga

Topics Initial Public Offering

Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development

October 10, 2023

Dr. Lenz brings 20 years of neuroscience drug development expertise, with deep experience implementing successful clinical programs to support the development of novel medicines

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Specialty Asian Grocer Maison Solutions Opens For Trading ↗

October 08, 2023

Following a couple of high-profile trading debuts, the IPO market slowed down again. There was only one public offering of note this week, with California-based specialty Asian grocer Maison Solutions...

Via Talk Markets

Topics Initial Public Offering

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 02, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations.

Via Benzinga

Ticking Time Bombs: 3 New Stocks to Dump Before the Damage Is Done (IPO) ↗

September 28, 2023

The IPO market is still far from being as hot as it was in 2021, and these three recently listed stocks are solid proof of that.

Via InvestorPlace

Topics Initial Public Offering

Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday ↗

September 28, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Shares of Neumora Therapeutics Slumped This Week ↗

September 21, 2023

The clinical-stage biotech just had its IPO last week.

Via The Motley Fool

Topics Initial Public Offering

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 20, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

Via Benzinga

SoftBank-Owned Arm Jumps 20% In Market Debut ↗

September 17, 2023

British chip designer Arm made its public debut on Thursday, with the shares jumping 10% right as the stock opened for trading. Arm's was the most high-profile Nasdaq IPO in the last few years, with...

Via Talk Markets

Topics Initial Public Offering

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.